Background and Aim: With the increase in life expectancy, the prevalence of aortic stenosis (AS) has increased as well. Transcatheter aortic valve implantation (TAVI) has been improved rapidly and become an important treatment option for inoperable and high risk patients. While the impact ofsurgical aortic valve replacement (s-AVR) or TAVI on the function of left ventricle has been studied with various imaging modalities, little is known about the impact on right ventricular (RV) function. In the current study, we evaluate the impact of TAVI on the RV function using conventional echocardiographic parameters. Methods: Echocardiography (Philips iE33) was performed prior to, immediately after, and 1 month after valve implantation. RV function was assessed using: (1) tricuspid annular plane systolic excursion (TAPSE), (2) RV Tissue Doppler Imaging (S'), (3) the right ventricular systolic pressure (RVSP), (4) Fractional area change (FAC) equation: FAC ¼ (end-diastolic area -end-systolic area)/ (end-diastolic area)x100. (5) The RV ejection fraction (RVEF) is calculated using Eq. RV ejection fraction ¼(enddiastolic volume-end-systolic volume)/(end-diastolic volume) Â 100. TAVI was performed through subclavian artery in 2 patients and transfemoral artery in 40 patients. Edwards Sapien XT (Edwards Lifesciences, Irvine, CA, USA) valve was used to all of the patients. Results: 42 patients were performed TAVI between October 2012 and April 2013. Of these 42 patients, 26 were female and 16 were male with a 78,2 years mean age. The average valve area was determined as 0,6 cm2 and average mean gradient as 54,6 mmHg in echocardiography. The average Society of Thoracic Surgeons (STS) score of the patients was 7,1 (co-morbidity as hematologic and cirrhosis, high risk according to surgeon), mean logistic EuroScore was %21,8 and %87 of them were in moderate and high risk groups according to SURTAVI risk model. The patients' average mean aortic valve gradient was 9,8 mmHg after the TAVI. No moderate or severe paravalvular aortic regurgitation was detected. After the procedure, there were no mortality, and 1 patient died of non-cardiac reasons within 30 days. Baseline, post-TAVI and 1st month after TAVI, mean RVSP (PASP) was 46,2, 39,6 and 41,2 mmHg respectively (p:0,04). There was statistically significant decrease RVSP with TAVI. When evaluated either by TAPSE (p:0,03), RVEF (p:0,02) FAC (p:0,009) and RV TDI S' (p:0,008) RV function was improved statistically significant with TAVI. Conclusion: It has been demonstrated that right ventricular systolic dysfunction develops soon after s-AVR. However, few studies have evaluated RV function in patients who had undergone TAVI. This study indicates that an improvement in RV function assessed by echocardiography and TDI could be seen already one month after TAVI. We conclude that patients with severe AS and a high surgical risk profile have a favorable change in RV function immediately and one month after TAVI. 
